Glycyrrhizin/Glycine/Cysteine Hydrochloride

Tier C — Watch / trade

Originator

2000

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：Not applicable

Indications (approved)：Liver disease, Stomatitis, Dermatitis, Urticaria, Pruritus, Eczema, 水疱, Respiratory tract infection

Regional status

China

Approved

2000-05-22

Japan

Approved

2003-07-01

Factories producing this API18

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

18 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Glycyrrhizin/Glycine/Cysteine Hydrochloride?

Approved indications include: Liver disease, Stomatitis, Dermatitis, Urticaria, Pruritus, Eczema, 水疱, Respiratory tract infection.

When does the Glycyrrhizin/Glycine/Cysteine Hydrochloride patent expire?

No public expiry year is available for Glycyrrhizin/Glycine/Cysteine Hydrochloride yet; this page updates once verified.

How do I get a quote for Glycyrrhizin/Glycine/Cysteine Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27